Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on August 7, 2003; DOI 10.1182/blood-2003-01-0175.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-01-0175v1
102/12/4115    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilangumaran, S.
Right arrow Articles by Rottapel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilangumaran, S.
Right arrow Articles by Rottapel, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted February 4, 2003
Accepted July 25, 2003

Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes

Subburaj Ilangumaran, Sheela Ramanathan, Terry Ning, Jose La Rose, Brandon Reinhart, Philippe Poussier, and Robert Rottapel*

Department of Experimental Therapeutics, Ontario Cancer Institute, Toronto, ON, Canada; Department of Rhematology, St. Michael's Hospital, Toronto, ON, Canada
Department of Immunology, Sunnybrook and Women's College Health Science Centre, Toronto, ON, Canada

* Corresponding author; email: rottapel{at}uhnres.utoronto.ca.

SOCS1-/- mice die prematurely from increased IFN{gamma} signaling with severe thymic atrophy and accelerated maturation of T cells. However, it was unclear whether the thymic defects were caused by SOCS1 deficiency or by increased IFN{gamma} signaling. Using SOCS1-/-IFN{gamma}-/- mice, we show in this study that SOCS1 deficiency skews thymocyte development towards CD8 lineage independently of IFN{gamma}. Fetal thymic organ cultures and intrathymic transfer of CD4-CD8- precursors into Rag1-/- mice show that the lineage skewing in SOCS1-/- mice is a T cell autonomous defect. Interestingly, SOCS1 is not required for attenuating IL-7 signaling at the CD4-CD8- stage but is essential to regulate IL-15 and IL-2 signaling in CD8+ thymocytes. IL-15 selectively stimulates SOCS1-/- CD8+ thymocytes inducing sustained STAT5 phosphorylation and massive proliferation. IL-15 also strongly upregulates Bcl-xL and CD44 in CD8+ thymocytes lacking SOCS1. SOCS1 gene is induced in CD4+ thymocytes by {gamma}c cytokines, whereas CD8+ thymocytes constitutively express SOCS1 mRNA even in the absence of cytokine stimulation. Since IL-15 is expressed by many different cell types, our results strongly suggest that SOCS1 functions as an indispensable attenuator of IL-15 receptor signaling in developing CD8+ thymocytes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Starr, M. Fuchsberger, L. S. Lau, A. P. Uldrich, A. Goradia, T. A. Willson, A. M. Verhagen, W. S. Alexander, and M. J. Smyth
SOCS-1 Binding to Tyrosine 441 of IFN-{gamma} Receptor Subunit 1 Contributes to the Attenuation of IFN-{gamma} Signaling In Vivo
J. Immunol., October 1, 2009; 183(7): 4537 - 4544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Saudemont, A. Hamrouni, P. Marchetti, J. Liu, N. Jouy, D. Hetuin, F. Colucci, and B. Quesnel
Dormant Tumor Cells Develop Cross-Resistance to Apoptosis Induced by CTLs or Imatinib Mesylate via Methylation of Suppressor of Cytokine Signaling 1
Cancer Res., May 1, 2007; 67(9): 4491 - 4498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ramanathan, J. Gagnon, C. Leblanc, R. Rottapel, and S. Ilangumaran
Suppressor of Cytokine Signaling 1 Stringently Regulates Distinct Functions of IL-7 and IL-15 In Vivo during T Lymphocyte Development and Homeostasis
J. Immunol., April 1, 2006; 176(7): 4029 - 4041.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. M. Davey, R. Starr, A. L. Cornish, J. T. Burghardt, W. S. Alexander, F. R. Carbone, C. D. Surh, and W. R. Heath
SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential
J. Exp. Med., October 17, 2005; 202(8): 1099 - 1108.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Hanada, K. Tanaka, Y. Matsumura, M. Yamauchi, H. Nishinakamura, H. Aburatani, R. Mashima, M. Kubo, T. Kobayashi, and A. Yoshimura
Induction of Hyper Th1 Cell-Type Immune Responses by Dendritic Cells Lacking the Suppressor of Cytokine Signaling-1 Gene
J. Immunol., April 1, 2005; 174(7): 4325 - 4332.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Alpdogan, J. M. Eng, S. J. Muriglan, L. M. Willis, V. M. Hubbard, K. H. Tjoe, T. H. Terwey, A. Kochman, and M. R. M. van den Brink
Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation
Blood, January 15, 2005; 105(2): 865 - 873.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Yoshimura, H. M. M. Ohishi, D. Aki, and T. Hanada
Regulation of TLR signaling and inflammation by SOCS family proteins
J. Leukoc. Biol., March 1, 2004; 75(3): 422 - 427.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020